Searched for
BIOASIA CONFERENCE 2025
India on the verge of becoming clinical trials hub, Parexel executive saysIndia is poised to become a prominent site for early-stage clinical trials, particularly amid the disruptions caused by the Russia-Ukraine ...- Amgen to invest $200 million in India site, CEO saysAmgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre,...
- Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its dru...
- Load More